Ken Marek, MD赞助的临床试验
总计90个结果
-
Ken Marek, MDInstitute for Neurodegenerative Disorders完全的
-
Gladwin, Mark, MD完全的
-
Mark Pimentel, MDBausch Health Americas, Inc.完全的
-
Gladwin, Mark, MDNational Institute on Aging (NIA)完全的
-
Schmidhofer, Mark, MDCystic Fibrosis Foundation; Mast Therapeutics, Inc.主动,不招人
-
Li Zhang, MD尚未招聘非小细胞癌 | 表皮生长因子受体基因突变中国
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
Facteurs Humains en SantéDominique FLETCHER MD-PhD; François Marty MD; Dinh Phong Nguyen MD; Loic Druette MD; Benoit Plaud... 和其他合作者完全的
-
Mark Pomerantz, MDMerck Sharp & Dohme LLC; Rainier Therapeutics终止
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Mark Garzotto, MDMerck Sharp & Dohme LLC; Astellas Pharma Inc招聘中
-
Oana Danciu, MDPfizer; Big Ten Cancer Research Consortium主动,不招人转移性乳腺癌 | 激素受体阳性乳腺恶性肿瘤 | 人类表皮生长因子 2 阴性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性肿瘤美国
-
Ajjai Alva, MDAstraZeneca; Big Ten Cancer Research Consortium主动,不招人
-
Monika Joshi, MDAstraZeneca主动,不招人
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI); Complexa, Inc.终止
-
Patrick Wen, MDBristol-Myers Squibb主动,不招人
-
Gladwin, Mark, MDNational Institutes of Health (NIH); National Institute on Aging (NIA)完全的
-
Mark Walters, MDUniversity of California, Berkeley; University of California, Los Angeles尚未招聘
-
Sacramento EP ResearchPadraig Gearoid O'Neill, MD; Mark R. Bowers, MS, MD; Anna M. Thiemann, BA; Shelley L. Allen, BSN... 和其他合作者完全的